EVO
Evotec SE ADR
NASDAQ: EVO · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$3.11
+5.78% today
Updated 2026-04-30
Market cap
$1.04B
P/E ratio
—
P/S ratio
1.33x
EPS (TTM)
$-0.34
Dividend yield
—
52W range
$2 – $5
Volume
0.1M
Evotec SE ADR (EVO) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
2 of 8
Last 8 quarters
Avg EPS surprise
-36.1%
Last 4 quarters
Revenue YoY growth
+25.5%
Most recent quarter
EPS YoY growth
+139.0%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
-2.7%
Last 4 reports
Positive reaction rate
75%
3 of 4 quarters
Largest single-day move
-16.8%
2025-11-05
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-04-01 | $0.05 | +82.8% | $2.50 | $2.59 | +3.6% |
| 2025-12-31 | $0.05 | -35.7% | $3.12 | $3.18 | +1.9% |
| 2025-11-05 | $-0.05 | +39.7% | $3.97 | $3.31 | -16.8% |
| 2025-08-13 | $-0.14 | -112.4% | $3.81 | $3.82 | +0.3% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2026-03-31 | $0.03 | $0.05 | +82.8% | $250.90M | +25.5% |
| 2025-12-31 | $0.07 | $0.05 | -35.7% | $253.27M | +14.5% |
| 2025-09-30 | $-0.08 | $-0.05 | +39.7% | $163.89M | -11.4% |
| 2025-06-30 | $-0.07 | $-0.14 | -112.4% | $171.24M | -6.0% |
| 2025-03-31 | $-0.12 | $-0.12 | -2.3% | $199.98M | -4.2% |
| 2024-12-31 | $0.00 | $-0.12 | — | $221.23M | +9.9% |
| 2024-09-30 | $-0.08 | $-0.12 | -50.0% | $184.89M | -5.8% |
| 2024-06-30 | $-0.06 | $-0.29 | -380.3% | $182.12M | — |
| 2024-03-31 | $-0.10 | $-0.06 | +40.0% | $208.73M | — |
| 2023-12-31 | $-0.03 | $-0.05 | -66.7% | $201.31M | — |
| 2023-09-30 | $-0.05 | $-0.12 | -140.0% | $196.28M | — |
Frequently asked questions
Has Evotec SE ADR beaten earnings estimates?
Evotec SE ADR has beaten Wall Street EPS estimates in 2 of its last 8 quarterly reports, with an average EPS surprise of -36.1% over the last 3 quarters.
How does EVO stock react to earnings?
EVO stock has moved an average of -2.7% in the trading day following earnings over its last 4 reports, with positive reactions in 75% of those quarters.
What is Evotec SE ADR's revenue growth rate?
Evotec SE ADR reported year-over-year revenue growth of +25.5% in its most recent quarter, with EPS growing +139.0% year-over-year.